Pharmacokinetics, urinary excretion and plasma protein binding of danofloxacin following intravenous administration in buffalo calves (Bubalus bubalis)

Veterinary Research Communications

Volumn 33, Issue 7, 2009, Pages 659-667

  Sappal, Ravinder ^a   Chaudhary, Rakesh Kumar ^a   Sandhu, Harpal Singh ^a   Sidhu, Pritam Kaur ^b  

^a GURU ANGAD DEV VETERINARY AND ANIMAL SCIENCES UNIVERSITY   (India)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Bovine; Danofloxacin; Dosing schedule; Intravenous; Pharmacokinetics

Indexed keywords

DANOFLOXACIN;

ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; AREA UNDER THE CURVE; ARTICLE; BUBALUS BUBALIS; BUFFALO; CALF (BOVINE); DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG URINE LEVEL; EQUILIBRIUM DIALYSIS; IN VITRO STUDY; LOADING DRUG DOSE; MALE; NONHUMAN; OPTIMAL DRUG DOSE; PLASMA PROTEIN BINDING; RECOMMENDED DRUG DOSE; STEADY STATE;

ANIMALS; BLOOD PROTEINS; BUFFALOES; FLUOROQUINOLONES; INJECTIONS, INTRAVENOUS; KINETICS; MALE; PROTEIN BINDING;

BOVINAE; BUBALUS BUBALIS;

EID: 70349232907     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11259-009-9215-6     Document Type: Article

References (34)

1. Ahangar AA. 1998. Effect of fever on pharmacokinetics and dosage regimen of enrofloxacin in cow calves. In: MVSc Thesis, Punjab Agricultural University, Ludhiana, India.
2. Aliabadi FS, Lees P. 2001. Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration. American Journal of Veterinary Research 62, 1979-1989. doi: 10.2460/ajvr.2001.62.1979
3. Aliabadi FS, Landoni MF, Lees P. 2003. Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids. Antimicrob Agents and Chemotherapy 47, 626-635. doi: 10.1128/AAC.47.2.626-635.2003
4. Apley MD, Upson DW. 1993. Lung tissue concentrations and plasma pharmacokinetics of danofloxacin in calves with acute pneumonia. American Journal of Veterinary Research 54, 937-943.
5. Arret B, Johnson DP, Krishbaum A. 1971. Outlines of details for microbiological assay of antibiotics: Second revision. Journal of Pharmaceutical Sciences 60, 1689-1694. doi: 10.1002/jps.2600601122
6. Atef M, El-Gendi AY, Aziza Amer MM, El-Aty AM. 2001. Some pharmacokinetic data for danofloxacin in healthy goats. Veterinary Research Communications 25, 367-77. doi: 10.1023/A:1010642726054
7. Bregnate MA, Saez P, Aramayona JJ, Fraile L, Garcia MA, Solans C. 1999. Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep and cows. American Journal of Veterinary Research 60, 1111-1116.
8. Brown SA. 1996. Fluoroquinolones in animal health. Journal of Veterinary Pharmacology and Therapeutics 19, 1-4. doi: 10.1111/ j.1365-2885.1996.tb00001.x
9. Cooper AC, Fuller JR, Fuller MK, Whittlestone P, Wise DR. 1993. In vitro activity of danofloxacin, tylosin and oxytetracycline against mycoplasmas of veterinary importance. Research in Veterinary Science 54, 329-334.
10. De Alwis MC. 1992. Haemorrhagic septicaemia-a general review. British Veterinary Journal 148(2), 99-112.
11. Drlica K. 2003. The mutant selection window and antimicrobial resistance. Journal of Antimicrobial Chemotherapy 52, 11-17. doi: 10.1093/jac/dkg269
12. Friis C. 1993. Penetration of danofloxacin into the respiratory tract tissues and secretions in calves. American Journal of Veterinary Research 54, 1122-1127.
13. Giles CJ, Magonigle RA, Grimshaw WTR, Tanner AC, Risk JE, Lynch MJ, Rice JR. 1991. Clinical pharmacokinetics of parenterally administered danofloxacin in cattle. Journal of Veterinary Pharmacology and Therapeutics 14, 400-410. doi: 10.1111/j.1365-2885.1991.tb00854.x
14. Giles CJ. 1996. Discovery and development of danofloxacin for treatment of respiratory disease in cattle. In: Proceedings of the Pfizer Scientific Symposium, Edinburgh, Scotland, UK.
15. Gibaldi M, Perrier D. 1982. In: Pharmacokinetics. 2nd edn, Marcel Dekker, New York.
16. Gupta A, Hammarlund-Udenaes M, Chatelain P, Mossingham R, Jonsson E. 2006. Stereoselective pharmacokinetics of cetitizine in the guinea pig: role of protein binding. Biopharmaceutics and Drug Disposition 27, 291-297. doi: 10.1002/bdd.509
17. Kaartinen L, Salonen M, Alli, Pyorala S. 1995. Pharmacokenetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows. Journal of Veterinary Pharmacology and Therapeutics 18, 357-362. doi: 10.1111/j.1365-2885.1995.tb00604.x
18. Mckellar QA, Gibson IF, McCormack RZ. 1998. Pharmacokinetics and tissue disposition of danofloxacin in sheep. Biopharmaceutics and Drug Disposition 19, 123-129. doi: 10.1002/ (SICI)1099-081X(199803)19:2<123::AID-BDD89>3.0.CO;2-G
19. McKellar QA, Gibson I, Monteiro A, Bregante M. 1999. Pharmacokinetics of Enrofloxacin and Danofloxacin in Plasma, Inflammatory Exudate, and Bronchial Secretions of Calves following Subcutaneous Administration. Antimicrobial Agents and Chemotherapy 43, 1988-1992.
20. Nouws JFM, Mevius DJ, Vree TB, Baars AM, Leurensen J. 1988. Pharmacokinetics, renal clearance and metabolism of ciprofloxacin following intravenous and oral administration to calves and pigs. Veterinary Quarterly 10, 156-163.
21. Petracca K, Riond JL, Graser T, Wanner M. 1993. Pharmacokinetics of the gyrase Inhibitor marbofloxacin: Influence of pregnancy and lactation in sows. Journal of Veterinary Medical Association 40, 73-79.
22. Pickerill KE, Paladino JA, Schentag JJ. 2000. Comparison of the fluoroquinolones based on pharmacokinetic and pharmacodynamic parameters. Pharmacotherapy 20 4, 417-428. doi: 10.1592/ phco.20.5.417.35062
23. Rowan TG, Sarasola P, Sunderland SJ, Giles CJ, Smith DG. 2004. Efficacy of danofloxacin in the treatment of respiratory disease in European cattle. Veterinary Record 154(19), 585-589.
24. Sarasola P, Lees P, AliAbadi FS, McKellar QA, Donachie W, Marr KA, Sunderland SJ & Rowan TG. 2002. Pharmacokinetic and pharmacodynamic profiles of danofloxacin administered by two dosing regimens in calves infected with Mannheimia (Pasteurella) haemolytica. Antimicrobial Agents and Chemotherapy 46(9), 3013-3019. doi: 10.1128/AAC.46.9.3013-3019.2002
25. Shojaee Aliabadi F and Lees P. 2003. Pharmacokinetic-pharmacodynamic integration of danofloxacin in the calf. Research in Veterinary Science 74 (3), 247-259. doi: 10.1016/S0034-5288(03)00005-5
26. Shem-Tov M, Ziv G, Glickman A and Saran A. 1997. Pharmacokinetics and penetration of danofloxacin from the blood into the milk of ewes. Veterinary Research 28, 571-579.
27. Shem-Tov M, Rav-Hon O, Ziv G, Lavi E, Glickman A and Saran A. 1998. Pharmacokinetics and penetration of danofloxacin from the blood into the milk of cows. Journal of Veterinary Pharmacoogy and Therapeutics 21, 209-213. doi: 10.1046/j.1365-2885.1998.00137.x
28. Sidhu PK. 2001. Pharmacokinetics and pharmacodynamics of marbofloxacin and tolfenamic acid in ruminant species. Ph.D. Dissertation, University of London, United Kingdom.
29. Srivastava AK, Dumka VK and Deol SS. 2000. Disposition kinetics and urinary excretion of pefloxacin after intravenous injection in crossbred calves. Veterinary Research Communication 24, 189-196. doi: 10.1023/ A:1006408415431
30. Toutain PL, Del Castillo JR, and Bousquet-Mélou A. 2002. The pharmacokinetic- pharmacodynamic approach to a rational dosage regimen for antibiotics. Research in Veterinary Science 73 (2), 105-114. doi: 10.1016/S0034-5288(02)00039-5
31. Toutain PL and Bousquet-Melou A. 2004. Plasma clearance. Journal of Veterinary Pharmacology and Therapeutics 27, 415-425. doi: 10.1111/ j.1365-2885.2004.00605.x
32. Verma R and Jaiswal TN. 1998. Haemorrhagic septicaemia vaccines. Vaccine 16(11-12), 1184-1192. doi: 10.1016/S0264-410X(98)80118-7
33. Wiuff C, Lykkesfeldt J, Svendsen O, Aarestrup FM. 2003. The effects of oral and intramuscular administration and dose escalation of enrofloxacin on the selection of quinolone resistance among Salmonella and coliforms in pigs. Research in Veterinary Science 75 (3), 185-193. doi: 10.1016/S0034-5288(03)00112-7
34. Zeitlinger MA, Sauermann R, Traunmuller F, Georgopoulos A, Muller M and Joukhadar C. 2004. Impact of plasma protein binding on antimicrobial activity using time-killing curves. Journal of Antimicrobial Chemotherapy 54, 876-880. doi: 10.1093/jac/dkh443